130 related articles for article (PubMed ID: 2073958)
1. Activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
[TBL] [Abstract][Full Text] [Related]
2. Preferential activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatology; 1992; 184(2):159-60. PubMed ID: 1498383
[No Abstract] [Full Text] [Related]
3. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
Takematsu H; Tagami H
Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
Takematsu H; Tagami H
Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
6. Complement activation during painful crisis in sickle cell anemia.
Mold C; Tamerius JD; Phillips G
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):314-20. PubMed ID: 7554454
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathway of complement is activated during in vitro ventricular assist.
Chen JC; Huynh TN; Serna DL; Sun CP; Ha H; Steward E; Webster S; Brenner M
J Investig Med; 1999 Nov; 47(9):502-6. PubMed ID: 10572381
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saarloos MN; Koenig RE; Spear GT
J Infect Dis; 1995 Oct; 172(4):1095-7. PubMed ID: 7561187
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
10. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
11. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in severe Plasmodium falciparum malaria.
Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
[TBL] [Abstract][Full Text] [Related]
13. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
14. Classical pathway complement activation in Kawasaki syndrome.
Kohsaka T; Abe J; Asahina T; Kobayashi N
J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
[TBL] [Abstract][Full Text] [Related]
15. Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro.
Tengvall P; Askendal A; Lundström I
Biomaterials; 1998 May; 19(10):935-40. PubMed ID: 9690835
[TBL] [Abstract][Full Text] [Related]
16. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
17. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation.
Vallhonrat H; Swinford RD; Ingelfinger JR; Williams WW; Ryan DP; Tolkoff-Rubin N; Cosimi AB; Pascual M
ASAIO J; 1999; 45(1):113-4. PubMed ID: 9952020
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
Buyon JP; Tamerius J; Belmont HM; Abramson SB
Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
[TBL] [Abstract][Full Text] [Related]
19. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous immunoglobulin treatment activates complement in vivo.
Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
